Oxford BioDynamics Plc OXBOF
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0014 Day range 0.0015
0.0014 52-week range 0.007
- YTD
- 0.00%
- 1 year
- -72.00%
- Open
- 0.0015
- Prev close
- 0.0014
- Mkt cap
- 18.82M
- Vol
- 174.57K
- Avg vol
- 6.98K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0014
- High
- 0.0015
3M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 9, 2026 | 3 weeks ago |
| RSI: Overbought | Oct 2, 2026 | 1 month ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| RSI: Overbought | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 4, 2026 | 2 months ago |
| RSI: Oversold | Aug 4, 2026 | 2 months ago |
News
- Oxford BioDynamics shares soar 33% after unveiling breakthrough blood test for Chronic Fatigue Syndrome
- Oxford BioDynamics unveils blood test for Chronic Fatigue Syndrome with 96% accuracy
- Oxford BioDynamics shares climb blood test findings
- Oxford BioDynamics partners with Google Cloud - ICYMI
- Oxford BioDynamics soars on new Google collab
- Oxford BioDynamics shares jump 66% after Pfizer validates blood-based cancer biomarker technology
- Oxford BioDynamics shares jump on UK lab accreditation for flagship cancer test
- Oxford BioDynamics slumps on warning of need for new funding
- Oxford BioDynamics part of consortium shortlisted for Strategic Government Initiative to Improve Cancer Immunotherapy
- Oxford Biodynamics tumbles as results knock froth off recent gains
Your note
Sign in to keep a note on OXBOF — it syncs with the Stock Master app.